Halozyme Therapeutics
HALO
#2141
Rank
$7.01 B
Marketcap
$55.15
Share price
-0.45%
Change (1 day)
28.98%
Change (1 year)

Halozyme Therapeutics (HALO) - Net assets

Net assets on the balance sheet as of March 2024 : $0.17 B

According to Halozyme Therapeutics's latest financial reports the company has $0.17 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Halozyme Therapeutics - Net assets on balance sheet (from 2002 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$83.8 M-50.64%
2022-12-31$$0.16 B-13.79%
2021-12-31$$0.19 B30.39%
2020-12-31$$0.15 B64.6%
2019-12-31$$91.76 M-63.13%
2018-12-31$$0.24 B19.45%
2017-12-31$$0.20 B-741.5%
2016-12-31$-$32.49 M-175.54%
2015-12-31$$42.99 M3.98%
2014-12-31$$41.35 M-306.86%
2013-12-31$-$19.99 M-140.92%
2012-12-31$$48.85 M348.19%
2011-12-31$$10.9 M-46.44%
2010-12-31$$20.35 M194.8%
2009-12-31$$6.9 M-55.11%
2008-12-31$$15.37 M-73.38%
2007-12-31$$57.76 M150.28%
2006-12-31$$23.08 M26.77%
2005-12-31$$18.2 M22.82%
2004-12-31$$14.82 M3865.75%
2003-12-31$$0.37 M-198.48%
2002-12-31$-$0.38 M-1761.97%
2001-12-31$$0.02 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
-$0.23 B-229.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.89 B 7,153.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.23 B 4,531.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$92.55 B 51,955.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$82.20 B 46,131.55%๐Ÿ‡ซ๐Ÿ‡ท France
$70.02 B 39,279.56%๐Ÿ‡บ๐Ÿ‡ธ USA